Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.
Saved in:
| Title: | Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. |
|---|---|
| Authors: | Gaud G; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA., Achar S; Immunodynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Bourassa FXP; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Quebec, Canada.; Department of Physics, McGill University, Montréal QC, Canada., Davies J; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Department of Safety Assessment, Genentech, Inc., San Francisco, CA, USA., Hatzihristidis T; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA., Choi S; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA., Kondo T; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Gossa S; Viral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., Lee J; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA., Juneau P; National Institutes of Health Library, Office of Research Services, National Institutes of Health, Bethesda, MD, USA., Taylor N; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Hinrichs CS; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., McGavern DB; Viral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA., François P; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Quebec, Canada.; Mila Québec, Montréal, Quebec, Canada., Altan-Bonnet G; Immunodynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Love PE; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA. lovep@mail.nih.gov. |
| Source: | Nature immunology [Nat Immunol] 2024 Mar; Vol. 25 (3), pp. 579. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38057618 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gaud+G%22">Gaud G</searchLink>; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Achar+S%22">Achar S</searchLink>; Immunodynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bourassa+FXP%22">Bourassa FXP</searchLink>; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Quebec, Canada.; Department of Physics, McGill University, Montréal QC, Canada.<br /><searchLink fieldCode="AU" term="%22Davies+J%22">Davies J</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Department of Safety Assessment, Genentech, Inc., San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hatzihristidis+T%22">Hatzihristidis T</searchLink>; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Choi+S%22">Choi S</searchLink>; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kondo+T%22">Kondo T</searchLink>; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gossa+S%22">Gossa S</searchLink>; Viral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+J%22">Lee J</searchLink>; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Juneau+P%22">Juneau P</searchLink>; National Institutes of Health Library, Office of Research Services, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Taylor+N%22">Taylor N</searchLink>; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hinrichs+CS%22">Hinrichs CS</searchLink>; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.; Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22McGavern+DB%22">McGavern DB</searchLink>; Viral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22François+P%22">François P</searchLink>; Département de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Quebec, Canada.; Mila Québec, Montréal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Altan-Bonnet+G%22">Altan-Bonnet G</searchLink>; Immunodynamics Section, Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Love+PE%22">Love PE</searchLink>; Hematopoiesis and Lymphocyte Biology Section, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MD, USA. lovep@mail.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2024 Mar; Vol. 25 (3), pp. 579. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38057618 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41590-023-01725-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 579 Titles: – TitleFull: Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gaud G – PersonEntity: Name: NameFull: Achar S – PersonEntity: Name: NameFull: Bourassa FXP – PersonEntity: Name: NameFull: Davies J – PersonEntity: Name: NameFull: Hatzihristidis T – PersonEntity: Name: NameFull: Choi S – PersonEntity: Name: NameFull: Kondo T – PersonEntity: Name: NameFull: Gossa S – PersonEntity: Name: NameFull: Lee J – PersonEntity: Name: NameFull: Juneau P – PersonEntity: Name: NameFull: Taylor N – PersonEntity: Name: NameFull: Hinrichs CS – PersonEntity: Name: NameFull: McGavern DB – PersonEntity: Name: NameFull: François P – PersonEntity: Name: NameFull: Altan-Bonnet G – PersonEntity: Name: NameFull: Love PE IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2024 Mar Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1529-2916 Numbering: – Type: volume Value: 25 – Type: issue Value: 3 Titles: – TitleFull: Nature immunology Type: main |
| ResultId | 1 |